Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 11:12:1589531.
doi: 10.3389/fmed.2025.1589531. eCollection 2025.

Characteristics of adverse drug reactions and risk management strategies for methylprednisolone sodium succinate in the treatment of idiopathic sudden sensorineural hearing loss: a clinical study of 1026 patients

Ting Wu #  1 , Yu Tang #  1 , Sinan Yan  1 , Jie Meng  1 , Shuangba He  1 , Wei Meng  1
Affiliations

Characteristics of adverse drug reactions and risk management strategies for methylprednisolone sodium succinate in the treatment of idiopathic sudden sensorineural hearing loss: a clinical study of 1026 patients

Ting Wu et al. Front Med (Lausanne). .

Abstract

Objective: To systematically analyze the patterns, risk factors, and clinical management strategies of adverse drug reactions (ADRs) associated with methylprednisolone sodium succinate in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).

Methods: A retrospective study was conducted on 1026 ISSNHL patients treated with methylprednisolone sodium succinate at Nanjing Tongren Hospital from January 2020 to December 2024. The incidence, types, severity, and outcomes of ADRs were recorded. Multivariate logistic regression was used to identify risk factors, and evidence-based intervention recommendations were proposed.

Results: The overall ADRs incidence was 17.2% (177/1026), with gastrointestinal reactions (43.5%), elevated blood glucose (29.9%), and neuropsychiatric symptoms (18.1%) being the most common. Advanced age (≥60 years, OR = 2.24) and diabetes (OR = 3.15) were independent risk factors for ADRs (both P < 0.05). Symptoms were alleviated in 98.3% of patients after intervention, and treatment was discontinued in 3 cases due to severe hyperglycemia.

Conclusion: The risk of ADRs from methylprednisolone sodium succinate is closely related to patients' underlying conditions and treatment regimens. A stratified warning system and optimized individualized treatment strategies are necessary.

Keywords: ADRs; ISSNHL; clinical management; evidence-based medicine; methylprednisolone sodium succinate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

References

    1. Smetak M, Jiramongkolchai P, Herzog J. Predicting hearing recovery for patients with iSSNHL. JAMA Otolaryngol Head Neck Surg. (2024) 150:906–7. 10.1001/jamaoto.2024.2634 - DOI - PubMed
    1. Tripathi P, Deshmukh P. Sudden sensorineural hearing loss: A review. Cureus. (2022) 14:e29458. 10.7759/cureus.29458 - DOI - PMC - PubMed
    1. Kitoh R, Nishio S, Sato H, Ikezono T, Morita S, Wada T, et al. Clinical practice guidelines for the diagnosis and management of acute sensorineural hearing loss. Auris Nasus Larynx. (2024) 51:811–21. 10.1016/j.anl.2024.06.004 - DOI - PubMed
    1. Tsuzuki N, Wasano K. Idiopathic sudden sensorineural hearing loss: A review focused on the contribution of vascular pathologies. Auris Nasus Larynx. (2024) 51:747–54. 10.1016/j.anl.2024.05.009 - DOI - PubMed
    1. Zhang L, Tan W, Song X, Wang S, Tang L, Chen Y, et al. Methylprednisolone attenuates lipopolysaccharide-induced sepsis by modulating the small nucleolar RNA host gene 5/Copine 1 pathway. DNA Cell Biol. (2021) 40:1396–406. 10.1089/dna.2021.0376 - DOI - PubMed

LinkOut - more resources